Why Harmony Biosciences (HRMY) Stock Is Down 18% Today
Why Harmony Biosciences (HRMY) Stock Is Down 18% Today
Additionally, a lock-up agreement restricts the sale of additional shares by key company insiders for 60 to 90 days.Harmony Biosciences Holdings Inc (NASDAQ:HRMY) shares are trading lower by 18.3% to $33.89 Wednesday afternoon after the company announced a public offering of up to 8 million shares of common stock by selling shareholders Marshman Fund Trust II and Valor IV Pharma Holdings.
Harmony Biosciences控股公司（納斯達克：HRMY）的股價週三下跌了18.3％，至33.89美元，因爲公司宣佈將發行多達800萬股普通股的公開要約，由出售股東Marshman Fund Trust II和Valor IV Pharma Holdings負責。
What Else: Harmony Biosciences is offering 8 million shares of common stock through selling shareholders, who have granted underwriters a 30-day option to buy up to an additional 1.2 million shares.
此外，Harmony Biosciences通過出售股東提供了800萬股普通股，這些股東已授予承銷商購買多達額外120萬股的權利。
The offering will not increase the company's outstanding share count, which will remain at 57,030,897 shares. Harmony will not receive any proceeds from this sale; all net proceeds go directly to the selling shareholders.
此次發行不會增加公司的流通股數量，其將保持在57,030,897股。Harmony將不會從這次銷售中獲得任何收益；所有淨收益直接歸銷售股東所有。
Additionally, a lock-up agreement restricts the sale of additional shares by key company insiders for 60 to 90 days.
此外，一項鎖定協議限制了關鍵公司內部人士在60至90天內出售額外股份。
Read Also: Wall Street Mixed, Semiconductors Tumble As AMD Disappoints, Alphabet Rallies, SMCI Plummets: What's Driving Markets Wednesday?
閱讀更多：華爾街走勢混雜，半導體下跌，AMD令人失望，Alphabet反彈，SMCI暴跌：週三市場的推動因素是什麼？
According to data from Benzinga Pro, HMRY has a 52-week high of $41.61 and a 52-week low of $22.03.
根據Benzinga Pro的數據，HMRY的52周最高價爲41.61美元，52周最低價爲22.03美元。
